Quarterly figures: Boom in weight loss injections continues - Eli Lilly raises forecast
The demand for weight loss and diabetes medications is bringing Eli Lilly strong growth. The US pharmaceutical company is raising its sales forecast for 2026 - and significantly exceeding expectations.
We haven't written up this one. Handelsblatt has the full story — the link below goes straight to it.




